ApprovalTrail

Drug · DIN 02298309

CHAMPIX

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since April 12, 2024; first marketed October 2, 2007.
Drug Identification Number (DIN)
02298309
Company (DIN owner)
Pfizer Canada UlcKirkland, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet; Kit
Route
Oral
Therapeutic class (ATC)
Varenicline N07BA03
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
VARENICLINE (VARENICLINE TARTRATE)0.5 MG
VARENICLINE (VARENICLINE TARTRATE)1 MG

Notices of Compliance

Health Canada approvals that name this DIN.

  • August 21, 2007: NOC 8984Supplement to a New Drug Submission (SNDS) · New drug identification number for the initial dosing pack

Recalls and safety alerts that mention it

Other DINs named CHAMPIX